FDA moves to permit oral contraceptive prescriptions without initial pelvic exam.
D000293:Adolescent; D000367:Age Factors; D000569:Americas; D001695:Biology; D002584:Cervix Uteri; D019411:Clinical Laboratory Techniques; D003267:Contraception; D003276:Contraceptives, Oral; D003695:Delivery of Health Care; D003710:Demography; D019049:Developed Countries; D003933:Diagnosis; D011307:Drug Prescriptions; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006077:Government Agencies; D006285:Health Planning; D006403:Hematologic Tests; D007878:Legislation as Topic; D009656:North America; D009934:Organization and Administration; D009938:Organizations; D010414:Pennsylvania; D010808:Physical Examination; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D014481:United States; D014566:Urogenital System; D014599:Uterus
D003276:Contraceptives, Oral
Adolescents; Adolescents, Female; Age Factors; Americas; Biology; Cervix; Contraception; Contraceptive Methods--contraindications; Demographic Factors; Developed Countries; Distributional Activities; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Female; Government Agencies; Hematologic Tests; Laboratory Examinations And Diagnoses; Laboratory Procedures; Legislation; North America; Northern America; Oral Contraceptives--contraindications; Organization And Administration; Organizations; Pennsylvania; Physical Examinations And Diagnoses; Physiology; Population; Population Characteristics; Prescriptions; Program Activities; Programs; Research Report; United States; Urogenital System; Uterus; Youth